|
|
Article: Deals
- Article from:
- Biopharm International
- Article date:
- November 1, 2005
- Author:
CopyrightCopyright Advanstar Communications, Inc. Nov 2005. Provided by ProQuest LLC. (Hide copyright information)
|
GenPat77 + BMBF Grant = Inflammatory Bowel Study
The Federal Ministry for Education and Research (BMBF) in Bonn, Germany has awarded funding to GenPat77 to support development of GenPat77's immunomodulator program in inflammatory bowel disease, CEACAMI,and for selection of the most promising biological therapeutic for clinical use. The award was dispersed as part of the BioChancePLUS support program, which assists small and medium-sized biotech companies in developing and implementing biotech processes and products.
TorreyPines Therapeutics+ Eisai = Alzheimer's Research
A joint research program has been formed between Torrey Pines Therapeutics and Eisai Co. Ltd., focusing on the discovery ...